Inhibiting angiogenesis is a promising strategy for treatment of cancer and several other disorders, including age-related macular degeneration. Major progress towards a treatment has been achieved over the past few years, and the first antiangiogenic agents have been recently approved for use in several countries. Therapeutic angiogenesis (promoting new vessel growth to treat ischaemic disorders) is an exciting frontier of cardiovascular medicine, but further understanding of the mechanisms of vascular morphogenesis is needed first. ©2005 Nature Publishing Group.
CITATION STYLE
Ferrara, N., & Kerbel, R. S. (2005, December 15). Angiogenesis as a therapeutic target. Nature. https://doi.org/10.1038/nature04483
Mendeley helps you to discover research relevant for your work.